Foresite Capital Management Vi Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Foresite Capital Management Vi Llc disclosed 23 stock positions valued at approximately $642.58M as of quarter-end June 30, 2026. The largest holdings include CG Oncology, Inc., ALUMIS INC., and Seaport Therapeutics, Inc..
- Report Period
- June 30, 2026
- No. of Stocks
- 23
- Portfolio Value
- $642.58M
Holdings by Sector
Foresite Capital Management Vi Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| CG Oncology, Inc. | CGON | Healthcare | 26.20% | 2,369,574 | +148,100 | +6.67% | $168,358,233 |
| ALUMIS INC. | ALMS | Healthcare | 18.60% | 4,247,670 | - | - | $119,529,434 |
| Seaport Therapeutics, Inc. | SPTX | Other | 6.02% | 1,779,521 | +1,779,521 | +100.00% | $38,651,196 |
| Denali Therapeutics Inc. | DNLI | Healthcare | 5.59% | 1,396,771 | +186,800 | +15.44% | $35,924,950 |
| Celldex Therapeutics, Inc. | CLDX | Healthcare | 5.09% | 879,713 | +563,800 | +178.47% | $32,734,121 |
| AGIOS PHARMACEUTICALS, INC. | AGIO | Healthcare | 4.53% | 785,000 | +260,000 | +49.52% | $29,131,350 |
| Corvus Pharmaceuticals, Inc. | CRVS | Healthcare | 4.26% | 1,831,233 | - | - | $27,358,621 |
| Parabilis Medicines, Inc. | PBLS | Other | 4.26% | 999,044 | +999,044 | +100.00% | $27,343,834 |
| GH Research PLC | GHRS | Other | 3.93% | 940,493 | +625,001 | +198.10% | $25,280,452 |
| Jade Biosciences, Inc. | JBIO | Other | 3.07% | 886,667 | +566,667 | +177.08% | $19,701,741 |
| Hinge Health, Inc. | HNGE | Healthcare | 2.85% | 220,400 | - | - | $18,293,200 |
| Kymera Therapeutics, Inc. | KYMR | Healthcare | 2.61% | 146,332 | - | - | $16,779,890 |
| AtaiBeckley Inc. | ATAI | Other | 2.26% | 2,750,000 | - | - | $14,492,500 |
| Verastem, Inc. | VSTM | Healthcare | 1.87% | 3,146,631 | - | - | $12,020,130 |
| Beam Therapeutics Inc. | BEAM | Healthcare | 1.76% | 330,000 | +330,000 | +100.00% | $11,325,600 |
| Minerva Neurosciences, Inc. | NERV | Healthcare | 1.71% | 1,985,584 | -1,016 | -0.05% | $11,019,991 |
| ArriVent BioPharma, Inc. | AVBP | Healthcare | 1.63% | 301,341 | +301,341 | +100.00% | $10,468,586 |
| Aura Biosciences, Inc. | AURA | Healthcare | 1.47% | 1,333,334 | +1,333,334 | +100.00% | $9,466,671 |
| Crinetics Pharmaceuticals, Inc. | CRNX | Healthcare | 1.23% | 212,010 | - | - | $7,933,414 |
| Research Alliance Corp III | RACC | Other | 0.50% | 300,000 | +300,000 | +100.00% | $3,210,000 |
| Zura Bio Ltd | ZURA | Other | 0.41% | 450,000 | - | - | $2,655,000 |
| Kailera Therapeutics, Inc. | KLRA | Other | 0.13% | 37,500 | +37,500 | +100.00% | $826,125 |
| Disc Medicine, Inc. | IRON | Healthcare | 0.01% | 970 | +970 | +100.00% | $70,946 |
Showing 23 of 23 holdings in the latest reporting period.